Background This study compares robotic‐assisted pancreatic surgery (R‐PS) and laparoscopic pancreatic surgery (L‐PS) outcomes in patients with pancreatic malignancies and medium‐ to high‐risk pancreatic fistulas. Materials and Methods A retrospective cohort study was conducted at Guangdong Provincial People's Hospital (2021–2023). The primary endpoints were major complications (Clavien‐Dindo grade ≥ III) and postoperative morbidity. Results 200 R‐PS and 400 L‐PS patients were included, with 163 pairs matched. R‐PS showed lower conversion rates (2.5% vs. 17.2%, p < 0.001), less blood loss (119 vs. 179 mL, p = 0.013), and faster function recovery (8.2 vs. 9.6 days, p = 0.038). Postoperatively, R‐PS had fewer pancreatic fistulas in malignant (4.1% vs. 32.6%, p < 0.001) and moderate to high‐risk cases (8.3% vs. 16.7%, p = 0.026). R‐PS benefits are not procedure‐specific. Conclusion R‐PS offers advantages in blood loss, complications, and fistula prevention, suggesting it may be preferable for complex pancreatic surgeries.
No takes yet. Share an insight, caveat, or question.
Zhong et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: